These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8894739)

  • 41. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.
    Kuhn J; Bewermeyer H; Miyajima H; Takahashi Y; Kuhn KF; Hoogenraad TU
    Brain Dev; 2007 Aug; 29(7):450-3. PubMed ID: 17307325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nervous system manifestation in aceruloplasminemia].
    Miyajima H
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1579-84. PubMed ID: 15384686
    [No Abstract]   [Full Text] [Related]  

  • 43. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.
    Bosio S; De Gobbi M; Roetto A; Zecchina G; Leonardo E; Rizzetto M; Lucetti C; Petrozzi L; Bonuccelli U; Camaschella C
    Blood; 2002 Sep; 100(6):2246-8. PubMed ID: 12200392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma.
    Yonekawa M; Okabe T; Asamoto Y; Ohta M
    Eur Neurol; 1999; 42(3):157-62. PubMed ID: 10529542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.
    Watanabe M; Ohyama K; Suzuki M; Nosaki Y; Hara T; Iwai K; Kono S; Miyajima H; Mokuno K
    Intern Med; 2018 Sep; 57(18):2713-2718. PubMed ID: 29709961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia.
    Kohno S; Miyajima H; Takahashi Y; Suzuki H; Hishida A
    J Neurol Sci; 2000 Dec; 182(1):57-60. PubMed ID: 11102640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical analysis of a missense mutation in aceruloplasminemia.
    Hellman NE; Kono S; Miyajima H; Gitlin JD
    J Biol Chem; 2002 Jan; 277(2):1375-80. PubMed ID: 11689569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease.
    Takahashi Y; Miyajima H; Shirabe S; Nagataki S; Suenaga A; Gitlin JD
    Hum Mol Genet; 1996 Jan; 5(1):81-84. PubMed ID: 8789443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant.
    Gok V; Ozcan A; Ozer S; Karaman F; Aykutlu E; Yilmaz E; Karakukcu M; Bisgin A; Unal E
    Pediatr Hematol Oncol; 2023; 40(7):673-681. PubMed ID: 36308763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel ceruloplasmin gene mutation causing aceruloplasminemia with diabetes in a Chinese woman: a case report.
    Xiao Y; Zhu C; Jiang F; Gao Q; Lu H; Wang C; Wei L
    Ann Palliat Med; 2022 Jul; 11(7):2516-2522. PubMed ID: 34670377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury.
    Patel BN; Dunn RJ; Jeong SY; Zhu Q; Julien JP; David S
    J Neurosci; 2002 Aug; 22(15):6578-86. PubMed ID: 12151537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux.
    Harris ZL; Durley AP; Man TK; Gitlin JD
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10812-7. PubMed ID: 10485908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia.
    Watanabe M; Asai C; Ishikawa K; Kiyota A; Terada T; Kono S; Miyajima H; Okumura A
    Intern Med; 2010; 49(15):1581-5. PubMed ID: 20686294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice.
    Kaneko K; Hineno A; Yoshida K; Ikeda S
    Neurosci Lett; 2008 Nov; 446(1):56-8. PubMed ID: 18804145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia.
    Oide T; Yoshida K; Kaneko K; Ohta M; Arima K
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):170-6. PubMed ID: 16599945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights.
    Loréal O; Turlin B; Pigeon C; Moisan A; Ropert M; Morice P; Gandon Y; Jouanolle AM; Vérin M; Hider RC; Yoshida K; Brissot P
    J Hepatol; 2002 Jun; 36(6):851-6. PubMed ID: 12044538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A fungal multicopper oxidase restores iron homeostasis in aceruloplasminemia.
    Harris ZL; Davis-Kaplan SR; Gitlin JD; Kaplan J
    Blood; 2004 Jun; 103(12):4672-3. PubMed ID: 14739215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic iron and glucose dysregulation in thalassemia major.
    Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
    Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceruloplasmin metabolism and function.
    Hellman NE; Gitlin JD
    Annu Rev Nutr; 2002; 22():439-58. PubMed ID: 12055353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.